Fortis Healthcare Board Meeting Scheduled to Approve Unaudited Financial Results

Fortis Healthcare has announced a board meeting scheduled for February 13, 2026, to consider and approve the unaudited financial results for the quarter and period ended December 31, 2025 (Q3). The company has also declared that the trading window will remain closed until 48 hours after the announcement of the financial results, up to February 15, 2026.

Board Meeting Announcement

A meeting of the Board of Directors of Fortis Healthcare is scheduled to be held on Friday, February 13, 2026. The primary purpose of this meeting is to review and approve the unaudited financial results of the company. These results pertain to the quarter and period that concluded on December 31, 2025 (Q3).

Trading Window Closure

Fortis Healthcare has also announced the continued closure of its trading window. As per the company’s communication, the trading window, which restricts trading in the company’s securities, will remain closed. This closure will persist until 48 hours following the official announcement of the financial results. Specifically, the trading window will be lifted after February 15, 2026.

Source: BSE

Previous Article

Greaves Cotton Board Approves Unaudited Financial Results for Q3 2026

Next Article

Prism Johnson Limited Investor Presentation on Q3 FY26 Results